368 related articles for article (PubMed ID: 26725998)
1. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
[TBL] [Abstract][Full Text] [Related]
2. Management of Hypersensitivity Reactions to Taxanes.
Picard M
Immunol Allergy Clin North Am; 2017 Nov; 37(4):679-693. PubMed ID: 28965634
[TBL] [Abstract][Full Text] [Related]
3. Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: Outcomes and risk factors.
Caiado J; Brás R; Paulino M; Costa L; Castells M
Ann Allergy Asthma Immunol; 2020 Sep; 125(3):325-333.e1. PubMed ID: 32353405
[TBL] [Abstract][Full Text] [Related]
4. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
Picard M; Castells MC
Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
[TBL] [Abstract][Full Text] [Related]
5. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
Feldweg AM; Lee CW; Matulonis UA; Castells M
Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
[TBL] [Abstract][Full Text] [Related]
8. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review.
Banerji A; Lax T; Guyer A; Hurwitz S; Camargo CA; Long AA
J Allergy Clin Immunol Pract; 2014; 2(4):428-33. PubMed ID: 25017531
[TBL] [Abstract][Full Text] [Related]
9. Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions.
Otani IM; Lax T; Long AA; Slawski BR; Camargo CA; Banerji A
J Allergy Clin Immunol Pract; 2018; 6(4):1266-1273.e2. PubMed ID: 28986119
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.
Kuo JC; Hawkins C; Yip D
Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214
[TBL] [Abstract][Full Text] [Related]
11. Cross-sensitivity between taxanes in patients with breast cancer.
Sánchez-Muñoz A; Jiménez B; García-Tapiador A; Romero-García G; Medina L; Navarro V; González-Sánchez LA; Alba E
Clin Transl Oncol; 2011 Dec; 13(12):904-6. PubMed ID: 22126735
[TBL] [Abstract][Full Text] [Related]
12. Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions.
Maurer K; Michener C; Mahdi H; Rose PG
J Gynecol Oncol; 2017 Jul; 28(4):e38. PubMed ID: 28541630
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.
Limsuwan T; Castells MC
Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity Reactions to Platinum Agents and Taxanes.
Tsao LR; Young FD; Otani IM; Castells MC
Clin Rev Allergy Immunol; 2022 Jun; 62(3):432-448. PubMed ID: 34338975
[TBL] [Abstract][Full Text] [Related]
15. Successful desensitization to docetaxel after severe hypersensitivity reactions in two patients.
Reeves DJ; Callahan MJ; Sutton GP
Am J Health Syst Pharm; 2012 Mar; 69(6):499-503. PubMed ID: 22382481
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and management of hypersensitivity reactions to chemotherapy agents.
Tham EH; Cheng YK; Tay MH; Alcasabas AP; Shek LP
Postgrad Med J; 2015 Mar; 91(1073):145-50. PubMed ID: 25659930
[TBL] [Abstract][Full Text] [Related]
17. Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies.
Picard M; Galvão VR
J Allergy Clin Immunol Pract; 2017; 5(3):600-609. PubMed ID: 28110056
[TBL] [Abstract][Full Text] [Related]
18. Role of Skin Tests in the Diagnosis of Immediate Hypersensitivity Reactions to Taxanes: Results of a Multicenter Study.
Pagani M; Bavbek S; Dursun AB; Bonadonna P; Caralli M; Cernadas J; Cortellini G; Costantino MT; Gelincik A; Lucchini G; Castells M
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):990-997. PubMed ID: 30292919
[TBL] [Abstract][Full Text] [Related]
19. [Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures].
Brault F; Waton J; Poreaux C; Schmutz JL; Barbaud A
Ann Dermatol Venereol; 2017 Nov; 144(11):685-695. PubMed ID: 28760501
[TBL] [Abstract][Full Text] [Related]
20. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
